Dr. Kamdar is a Principal at Domain Associates. Present board memberships include Rox Pharmaceuticals, Syndax, Tragara, and Tramoxia, as well as observer status at GenVault and Achaogen. Additionally, Dr. Kamdar serves as an advisory board member for Evolvence US-India Life Sciences. Before joining Domain, Dr. Kamdar was a Kauffman Fellow with MPM Capital. Dr. Kamdar was formerly a Research Director at Novartis. She built and led a research team that focused on the biology, genetics, and genomics of model organisms to uncover small molecules that modulated signaling pathway networks. Dr. Kamdar is a founder of Aryzun Pharmaceuticals, a biotech company utilizing protein-protein interaction mapping for small-molecule discovery with an initial focus on anti-infectives and oncology. Dr. Kamdar is the author of 11 papers as well as an inventor on seven patents. Dr. Kamdar received her BA from Northwestern University and her PhD from Emory University.